Live Status Check

NCT00478712 Recruiting Status

Real-time enrollment status for this hirschsprung disease clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: July 17, 2026 at 5:14 AM UTC

NCT00478712 Status Summary

NCT NumberNCT00478712
Recruiting StatusRecruiting
ConditionHirschsprung Disease
PhaseClinical Trial
Target Enrollment3,000 participants
Active Locations1 sites in the US
SponsorNYU Langone Health
Last Updated on CT.govJune 4, 2026 (Jun 4, 2026)

About NCT00478712 Enrollment Status

As of July 17, 2026: Clinical trial NCT00478712 is currently recruiting participants. This clinical trial study for hirschsprung disease is actively seeking new participants at 1 location across the United States. The study is sponsored by NYU Langone Health. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT00478712

Is NCT00478712 still recruiting?

Yes, NCT00478712 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT00478712 recruiting?

This trial is recruiting at 1 location in the United States. View all available locations on the full study page.

How do I enroll in NCT00478712?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT00478712 status last updated?

The official ClinicalTrials.gov record for NCT00478712 was last updated Jun 4, 2026 (June 4, 2026). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial